Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Routine vaccines refer to a standardized group of immunizations recommended by health authorities, such as the Centers for Disease Control and Prevention (CDC) and the World Health Organization (WHO), to protect individuals and populations from preventable infectious diseases (CDC, 2023). Unlike a specific molecular target such as a receptor or enzyme, routine vaccines are complex biological products that act as therapeutic agents to prime the host's immune system. They utilize various platforms, including live-attenuated, inactivated, subunit, or mRNA technologies, to present antigens to the immune system (StatPearls, 2023). This interaction triggers the adaptive immune system to develop long-term immunological memory, effectively preventing future infections or significantly reducing disease severity. Routine vaccines are a cornerstone of global public health, aimed at achieving herd immunity and controlling the spread of pathogens like poliovirus, measles, and hepatitis (WHO, 2023). Because the term describes a clinical category of products rather than a single biochemical entity, it is not classified as a traditional pharmacological target.
Routine vaccines function by introducing specific antigens—such as weakened or killed pathogens, or pieces of proteins—to the host immune system to stimulate a primary immune response without causing the disease itself (WHO, 2023). This process leads to the production of neutralizing antibodies by B-cells and the generation of memory B and T-cells, which provide rapid and effective protection upon subsequent exposure to the actual pathogen (NIH, 2023).
7 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Routine vaccines.